Navigation Links
Keppra XR(TM) Extended-Release Tablets Filed with the FDA
Date:1/16/2008

r information

Andrea Levin

Public Relations Manager, CNS, UCB

T 770.970.8352

M 404.483.7329

Andrea.levin@ucb-group.com

Sarah Handza

Cooney/Waters Group

T 212.886.2206

M 646.236.1458

Shandza@cooneywaters.com

About UCB

UCB, Brussels, Belgium (http://www.ucb-group.com) is a global leader in the biopharmaceutical industry dedicated to the research, development and commercialisation of innovative pharmaceutical and biotechnology products in the fields of central nervous system disorders, allergy/respiratory diseases, immune and inflammatory disorders and oncology. UCB focuses on securing a leading position in severe disease categories. Employing more than 10,000 people in over 40 countries, UCB achieved revenue of 3.5 billion euro in 2006 on a pro forma basis. UCB S.A. is listed on the Euronext Brussels Exchange and through its affiliate. SCHWARZ PHARMA AG (Monheim, Germany) is a member of the UCB Group.

Forward-looking statement

This press release contains forward-looking statements based on current plans, estimates and beliefs of management. Such statements are subject to risks and uncertainties that may cause actual results to be materially different from those that may be implied by such forward-looking statements contained in this press release. Important factors that could result in such differences include: changes in general economic, business and competitive conditions, effects of future judicial decisions, changes in regulation, exchange rate fluctuations and hiring and retention of its employees.


'/>"/>
SOURCE UCB
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. UCB Announces Positive Phase III Trial Results for Keppra XR(TM) (levetiracetam) Extended-Release Tablets
2. SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia
3. AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression
4. New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR(R) (zolpidem tartrate extended-release) Tablets CIV
5. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
6. A Phase II, Randomized, Double Blind, Placebo-Controlled Dose-Escalating Study, Meets the Clinical Endpoints of MTR106 Tablets During the Treatment of Acute Migraine Attacks Without Aura in Females
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... YORK , March 30, 2015 ... based nurse call systems," announced the high level ... with the ClinicAll infotainment systems. The ... on patient entertainment terminals; this allows patients to ... on their need and acuity. The advanced functionality ...
(Date:3/30/2015)... CUPERTINO, Calif. , March 30, 2015 /PRNewswire/ ... announced that it has initiated a multi-dose Phase ... DUR-928, the lead molecule in DURECT,s Epigenomic Regulator ... entity (NCE) that may have broad applicability in ... (NAFLD) and nonalcoholic steatohepatitis (NASH).  It may also ...
(Date:3/30/2015)... 30, 2015  BioPharmX Corporation (OTCQB: BPMX), a ... novel drug delivery products to address unmet needs ... the appointment of Stephen Morlock , a ... its board of directors.  Mr. Morlock,s background will ... its national roll-out of Violet iodine, the new, ...
Breaking Medicine Technology:NiQ Health Announces CarePlus(TM) Integration with ClinicAll 2DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 2DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 3DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 4BioPharmX Corporation Appoints Stephen Morlock To Its Board Of Directors 2BioPharmX Corporation Appoints Stephen Morlock To Its Board Of Directors 3
(Date:3/30/2015)... Vancouver personal injury lawyer firm, Jiwa Law ... taken up by the firm are settled before they ... protect the interests of their clients without them having ... comes across as an achievement for the personal injury ... to their client, without compromising their rights. , ...
(Date:3/30/2015)... This report studies the global tumor ablation market ... , Based on the type of technology, the ... major segments, namely radio-frequency, microwave, cryoablation and other ... ablation) segments. Moreover, based on type of departments, ... three segments, namely, interventional radiology, surgery and oncology. ...
(Date:3/30/2015)... 30, 2015 This report studies ... over the forecast period of 2014 to 2019. ... CAGR of 6.5% from 2014 to 2019. , ... this report, the global pharmacovigilance and drug safety ... on the basis of functionality, namely, adverse event ...
(Date:3/30/2015)... 2015 On March 19th, 2015, in ... of the Detroit Lions, LiveToBeSober.org hosted the “Fighting Addiction ... ministers and bishops as well as other civic leaders ... at the luncheon, including retired Detroit Lions wide receiver ... and two survivors of their own personal battles with ...
(Date:3/30/2015)... Dr. Shahdad Arami is now ... receive $200 off their Invisalign treatment. Many people crave ... a mouthful of metal. Invisalign offers an alternative. According ... is effective for straightening teeth but has no aesthetic ... oral appearance. The Invisalign system allows both teenagers and ...
Breaking Medicine News(10 mins):Health News:Jiwa Law Corporation States That Majority of Their Cases Get Settled Before Trial 2Health News:The Global Tumor Ablation Market is Poised to Reach the Value of $462.0 Million in 2019 - MarketsandMarkets Released Recently 2Health News:The Global Tumor Ablation Market is Poised to Reach the Value of $462.0 Million in 2019 - MarketsandMarkets Released Recently 3Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 2Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 3Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 4Health News:LiveToBeSober.org Releases Highlight Reel of Substance Abuse Conference Keynote Speakers 2Health News:Northridge Cosmetic Dentist, Dr. Arami, is Now Offering a New Promotion on Invisalign 2
... cause of autism a distant and discredited memory, scientists ... of the condition, which affects millions of children and ... of Chemical & Engineering News. C&EN is the weekly ... scientific society. In the story, C&EN Associate Editor ...
... 2012 Researchers at Wake Forest Baptist Medical Center have ... cancer, a distinction that could lead to more effective treatments ... professor of surgery and chief of the surgical oncology service ... of cases covering a 10-year period. It appears in the ...
... one Michigan State University professor will explore why in old ... whites. Prior research also shows of those 71 years ... mild cognitive impairment, or various types of mental processing problems, ... first to produce statistics about life expectancy with and without ...
... Mar 07, 2012-200 million teenagers suffer from depression ... results have led to increased controversy surrounding the ... on the latest research findings on antidepressant medications ... by Journal of Child and Adolescent Psychopharmacology (http://www.liebertpub.com/cap), ...
... Kan. -- In residential neighborhoods near manufacturing industries, ... than refreshing depending on the location, finds a ... Saugata Datta, assistant professor of geology at ... University and Johns Hopkins Bloomberg School of Public ...
... Medicine (BUSM) and Boston Medical Center (BMC) have found ... MRIs or ultrasounds) as part of breast pain evaluation, ... from these additional studies. These findings currently appear on-line ... Breast pain is a common breast health complaint, but ...
Cached Medicine News:Health News:Wake Forest Baptist research sheds light on cancer of the appendix 2Health News:New research will shed light on racial gap in dementia 2Health News:More effective treatments urgently needed for adolescent depression 2Health News:Manganese concentrations higher in residential neighborhoods than industrial sites, varies by region 2Health News:Manganese concentrations higher in residential neighborhoods than industrial sites, varies by region 3Health News:Research finds little benefit of breast imaging tests for women with breast pain 2
... with 3 charging wells. Available In 4 ... and Cinnamon. Spring balanced refractor and slit ... construction for lifelong quality. Sealed hydraulic system ... movement. Chair back reclines manually to fully ...
Our Ophthalmic Diagnostic Sets offer everything an eye care specialist needs. Complete your set with your choice of ophthalmoscope, retinoscope, handle, and case....
... and technological innovation are standard in ... created for Optometry students, the 18335-SDS ... 3.5V Coaxial-Plus Ophthalmoscope, the superior illumination ... cool halogen illumination of the Finnoff ...
Our 3.5v Streak or Spot Retinoscope Sets feature instruments with the brightest light output in the industry, reliable handles, and convenient cases....
Medicine Products: